James Wassil
Chief Operating Officer at VAXCYTE, INC.
Net worth: 15 M $ as of 31/05/2024
James Wassil active positions
Companies | Position | Start | End |
---|---|---|---|
VAXCYTE, INC. | Chief Operating Officer | 01/12/2019 | - |
Career history of James Wassil
Former positions of James Wassil
Companies | Position | Start | End |
---|---|---|---|
ICOSAVAX, INC. | Director/Board Member | 01/06/2022 | 19/02/2024 |
Independent Dir/Board Member | 01/06/2022 | 19/02/2024 | |
PFIZER, INC. | Corporate Officer/Principal | 01/05/2015 | 01/12/2019 |
NOVARTIS AG | Corporate Officer/Principal | 01/08/2008 | 01/05/2015 |
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Corporate Officer/Principal | - | - |
MERCK & CO., INC. | Sales & Marketing | - | - |
Training of James Wassil
University of Notre Dame | Undergraduate Degree |
Lehigh University | Graduate Degree |
Statistics
International
United States | 8 |
Switzerland | 2 |
Operational
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
Sales & Marketing | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
VAXCYTE, INC. | Health Technology |
PFIZER, INC. | Health Technology |
NOVARTIS AG | Health Technology |
MERCK & CO., INC. | Health Technology |
Private companies | 2 |
---|---|
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Commercial Services |
Icosavax, Inc.
Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- James Wassil
- Experience